A recent study highlights the occurrence of uveitis in patients with Blau syndrome despite treatment with adalimumab. This finding suggests the need for alternative therapeutic strategies in managing this rare condition.
uveitis despite adalimumab therapy in blau syndrome
Original title: “Uveitis despite adalimumab therapy in Blau syndrome.”